Associated with neuroinflammation and drug development laboratory of Prof Trent Woodruff after completing a PhD on the pharmacokinetics of complement C5a receptor antagonists. Currently working on the preclinical development of novel therapeutics for neurodegenerative disease. Conducted various bioanalytical studies aimed at progressing new therapeutics towards clinical trials with the help of quantitative and qualitative metabolomics, proteomics and lipidomics skills.